2014
DOI: 10.5144/0256-4947.2014.328
|View full text |Cite
|
Sign up to set email alerts
|

Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease

Abstract: BACKGROUND AND OBJECTIVESThis study is to evaluate the outcome of cataract surgery in patients with refractory uveitis associated with Behçet disease (BD) treated with infliximab.DESIGN AND SETTINGSA retrospective study in a university-based tertiary referral center in the period between July 2003 and November 2011.METHODSThis is a retrospective study of patients with refractory uveitis associated with BD who underwent phacoemulsification cataract surgery under systemic infliximab therapy between July 2003 and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 31 publications
0
5
0
Order By: Relevance
“…Cataracts: The formation of cataracts is one of the most common eye diseases (Alfawaz et al, 2014;Miric et al, 2014). In recent years, some researchers have found that there is a correlation between occurrence in cataracts and the oxidation index.…”
Section: Antioxidant Effects In Human and Animal Diseases Atherosclerosismentioning
confidence: 99%
“…Cataracts: The formation of cataracts is one of the most common eye diseases (Alfawaz et al, 2014;Miric et al, 2014). In recent years, some researchers have found that there is a correlation between occurrence in cataracts and the oxidation index.…”
Section: Antioxidant Effects In Human and Animal Diseases Atherosclerosismentioning
confidence: 99%
“…Although not formally approved for NIU, there are an important number of studies with infliximab specifically in two underlying conditions: Behc ßet disease and juvenile idiopathic arthritis (Levy-Clarke et al 2014;Cordero-Coma & Sobrin 2015). Moreover, evidence of the efficacy and safety of adalimumab and infliximab in adult NIU may also be found in case reports (Leccese et al 2011;Takase et al 2011;Zmuda et al 2013;Capote et al 2014;Ermetcan et al 2014;Achille et al 2016;Sakurai et al 2016), retrospective case series (Mushtaq et al 2007;Sobrin et al 2007;Handa et al 2011;Okada et al 2012;Al Rashidi et al 2013;Dobner et al 2013;Alfawaz et al 2014;van Denderen et al 2014;Interlandi et al 2014;Kruh et al 2014;Takeuchi et al 2014;Kim et al 2016;Vallet et al 2016;Durrani et al 2017) and prospective case series (Joseph et al 2003;Diaz-Llopis et al 2008;Rudwaleit et al 2009;Suhler et al 2009Suhler et al , 2013D ıaz-Llopis et al 2012;Erckens et al 2012).…”
Section: Rationale For Intravitreal Administration Of Anti-tnf Drugsmentioning
confidence: 97%
“…Atrophy of the optic nerve or retina involving the macula is associated with poor visual outcomes in uveitic eyes after cataract surgery. [ 11 18 ] In patients with advanced, mature cataracts that prevent fundus examination, B-scan ultrasonography can be performed to rule out retinal detachment, choroidal thickening, and vitritis. Optical coherence tomography (OCT) is necessary for ruling out macular edema, atrophy, holes, and epiretinal membranes.…”
Section: P Reoperative C Onsiderationmentioning
confidence: 99%
“…Alternatively, intravenous methylprednisolone 1 g/day (15–30 mg/kg of body weight for children) for 3 days can be used perioperatively to control inflammation. [ 5 11 18 20 25 ] Meacock et al . reported that a single dose of intravenous methylprednisolone (15 mg/kg) at 30 min before surgery is equivalent to a 2-week course of oral prednisolone (0.5 mg/kg) with respect to visual outcomes and postoperative CME development.…”
Section: P Reoperative C Onsiderationmentioning
confidence: 99%
See 1 more Smart Citation